Procter & GamblePGDON'T BUYApr 30, 2014Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
Great company and one that has excelled over the years, but trading at around 18X earnings right now. The consumer packaged space is really a slow growth space. If they can get 2%-3% revenue growth, they are happy. It just doesn’t support an 18 multiple. A lot of money has flowed into this because of an attractive dividend, but he would be a little bit concerned with the capital given the multiple and where it is.